Deconstructing the Potency and Cell-Line Selectivity of Membranolytic Anticancer Peptides

Cristina Martinez-Hernandez1, Mariana Del Carmen Aguilera-Puga1,2, Fabien Plisson1,2

  • 1Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Unidad de Genómica Avanzada, Laboratorio Nacional de Genómica para la Biodiversidad (Langebio), Irapuato, Guanajuato, 36824, Mexico.

Summary

Researchers explored how anticancer peptides can be more selective for cancer cells. Increasing peptide net charge or flexibility improves selectivity between cancer cell lines, offering a path to targeted cancer therapies.

Related Concept Videos